Bayer (FRA:BAYN) Given a €70.00 Price Target by JPMorgan Chase & Co. Analysts

JPMorgan Chase & Co. set a €70.00 ($81.40) target price on Bayer (FRA:BAYN) in a research report sent to investors on Monday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the healthcare company’s stock.

BAYN has been the subject of a number of other reports. Baader Bank set a €123.00 ($143.02) price objective on shares of Bayer and gave the stock a buy rating in a research report on Thursday, June 27th. Kepler Capital Markets set a €70.00 ($81.40) price objective on shares of Bayer and gave the stock a neutral rating in a research report on Thursday, June 27th. Deutsche Bank reduced their price objective on shares of Xilinx from $125.00 to $120.00 and set a hold rating for the company in a research report on Thursday, April 25th. DZ Bank upgraded shares of Telefonica from a hold rating to a buy rating in a research report on Tuesday, May 14th. Finally, Barclays upped their price objective on shares of Intuit from $225.00 to $237.00 and gave the stock an equal weight rating in a research report on Friday, May 24th. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating and twelve have assigned a buy rating to the company’s stock. The company presently has an average rating of Hold and an average price target of €80.67 ($93.81).

BAYN opened at €59.76 ($69.49) on Monday. The company has a fifty day moving average price of €56.55. Bayer has a 1 year low of €91.58 ($106.49) and a 1 year high of €123.82 ($143.98).

Bayer Company Profile

Bayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Further Reading: Options Trading – Understanding Strike Price

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit